The intent of the ethical guidelines and regulations, developed over time, that govern research on human subjects is to ensure that research participants are well-informed volunteers, protectedfrom harm, ensured potential benefit, and enrolled in an egalitarianfashion. This study discusses ethical issues that researchers and program planners grapple with in the area of sexual and reproductive health. We illustrate the dilemmas that arise in the application of the ethical principles, how they have been addressed, lessons learned, and remaining challenges. The ethical guidelines and regulations that govern re search on human subjects have evolved during the past six decades, notably in response to lapses that have oc curred. Today, the three principles of respect for indi viduals, beneficence, and justice are widely accepted and guide most research endeavors. Current research guide lines have been developed to ensure that participants are well-informed volunteers, protected from harm, guar anteed potential benefit, and enrolled in projects in an egalitarian manner.
The ethical guidelines and regulations that govern re search on human subjects have evolved during the past six decades, notably in response to lapses that have oc curred. Today, the three principles of respect for indi viduals, beneficence, and justice are widely accepted and guide most research endeavors. Current research guide lines have been developed to ensure that participants are well-informed volunteers, protected from harm, guar anteed potential benefit, and enrolled in projects in an egalitarian manner.
The ethical issues that researchers and program plan ners grapple with in the area of sexual and reproductive health are discussed here, illustrated with examples of the dilemmas that arise in the application of the ethical prin ciples, how they have been addressed, lessons that have been learned, and challenges that remain. The examples are drawn from research contexts and service-delivery situations.
Researchers are required to address questions that concern the nature and value to society of a proposed study, the development of a rigorous design, the recruit ment of participants, and the implementation of the re search. Some types of research can yield valuable infor mation but may be difficult to implement because they address sensitive issues. Such sensitive topics include sexual violence and domestic abuse in some settings and induced abortion in others. The sensitivity of an issue depends on its cultural, social, economic, legal, and po litical context.
The feasibility of conducting the research and the ramifications thereof are considerations that researchers must take into account. A study that cannot produce sci entifically valid results is not worth undertaking. The de sign of a study is as important as the issue being studied. Researchers usually discard findings of doubtful quality because little knowledge of value is produced. Some times research findings continue to be used even though the research study violated all ethical and humane stan dards. For example, the Nazi experiments conducted on concentration camp prisoners at Dachau in the early 1940s were blatantly inhumane, but decades after the Sec ond World War these experiments continued to be cited (Berger 1990) . Some ethicists have argued that the find ings continue to be cited largely because researchers are unaware of the poor quality of the science (Angell 1997; Berger 1990). In addition to being barbaric, these experi ments were poorly designed and haphazardly conducted, yielding results of little or no scientific value.
Another set of issues revolves around the recruit ment of research participants, especially from vulnerable populations. Participants can be at risk of harm on many counts and may not be able to make well-considered de cisions about their participation. Women in patriarchal societies may have limited personal autonomy; children and adolescents may lack the maturity to make thought ful decisions; and men who have sex with men may be so socially marginalized that they prefer to be unseen and unheard. Researchers are required to consider whether to include individuals from such vulnerable populations and, if they choose to do so, must take care in approach ing them and consider how to protect them from harm. Related concerns include how to guarantee that people's participation is voluntary (uncoerced by force or incen tives) and how to ensure that their consent is informed.
The implementation of the research, especially data collection, is a key phase of the process that can have ethical overtones. Some data-collection procedures may be inconvenient but otherwise benign, as in longitudinal studies that track respondents over time, requiring mul tiple interactions with the research team. Other proce dures may be not only inconvenient but also invasive or uncomfortable, for example, the collection of biological samples. Such sample collection may involve testing for infections and conditions such as sexually transmitted infections (STIs), including HIV, that are socially stigma tizing. Other issues include the mechanism of conveying test results to the respondent in a discreet and thoughtful manner and obtaining appropriate referrals or informa tion for management options in the event that a test result requires medical follow-up. Often the research context can call attention to the roles and responsibilities of researchers. Studies of the functioning of health services typically employ inde pendent and neutral observers to gauge the level of care provided by nursing staff. Situations may arise, howev er, that require the researcher to intervene, for example, when appropriate medical attention is not provided or when factually inaccurate and potentially damaging in formation is presented. In such situations, the researcher must plan in advance when to intervene and what spe cific actions to take. The research protocol is the document prepared be fore the study commences that describes to an institution al review board (IRB) the steps in the research process. The protocol presents the rationale for the study, includ ing its anticipated results, the study design, and its poten tial benefits and harms. The protocol lays out explicitly the criteria for including or excluding study participants; the recruitment mechanism; payment to participants, if any; and the informed-consent procedure. It provides guidelines for data collection and the arrangements that the researcher has made to ensure that participants are not unduly stressed by the data-collection procedure. The protocol binds the researcher to conduct the research as documented.
Policy and program planners, managers, and service providers grapple with a different set of ethical questions. These may range from the design of a package of servic es intended to promote good health and uphold human rights to the organization and delivery of services intend ed to ensure equitable access for potential beneficiaries. greater consensus concerning the purpose of research, the way it is conducted, and the anticipated findings. A good illustration of the type and level of current research debate is provided by the discussion of the clinical trials of the drug AZT to reduce mother-to-child transmission of HIV in developing countries.' At the time the clinical trials were being conducted, an alternate regi men of AZT called 076 had been found to be effective in developed countries; this regimen was found to reduce vertical transmission of HIV by 60 percent. Nevertheless, it was expensive and required intense and systematic inputs from the health system.2 Pregnant women had to undergo HIV testing and receive counseling early in pregnancy, adhere to a lengthy pill regimen, and refrain from breastfeeding. Furthermore, the health system had to have the capacity to administer AZT during labor and delivery and to provide systematic and early antenatal care (see Wood et al. 2002) . The high cost of the drug and the inputs required from the health system were found to be prohibitive for developing countries. For these rea sons, researchers undertook placebo-controlled studies of a less-expensive and shorter course of AZT that could be used in such settings. This approach became the center of a debate, however, between researchers who objected to the use of a control when an effective therapy was avail able and others who believed that the effective therapy was not a realistic option in developing countries ( The Belmont Report describes "research" as any ac tivity designed to develop or add knowledge that can be corroborated by accepted scientific observation or inference. By contrast, "practice" involves activities de signed to enhance the well-being of an individual patient through diagnosis, preventive treatment, or therapy (NCPHSBBR 1979) . Despite the differences between re search and practice, the issues in implementing a good informed-consent process are similar in both contexts.
Informed consent is often understood to be a mo ment in time in which a patient agrees to a procedure and a signature is obtained on a form (Macklin 1999). Prac titioners often talk about "getting consent" as though it were a one-time event on a checklist that stands in the way of conducting a procedure or enrolling an individ ual in a study. In recent years, however, the discourse on informed consent, particularly in the reproductive health field, has evolved to consider it to be a process involving ongoing communication between provider and patient (Wood et al. 2002) . This process-oriented approach highlights three distinct aspects of informed consent: disclosure, or provision of information by the researcher or service provider to the study participant, client, or patient; the participant's, patient's, or client's comprehension of the information; and his or her volun tary decisionmaking.
Disclosure is often the issue that providers focus on because it is largely within their control. Regulations and guidelines from regulatory authorities and other national or international groups with research oversight, such as the United States Food and Drug Administration, man date specific items that must be contained in informed consent forms in research. These include the purpose of the study, a description of the procedures or interven tion to be undertaken, the potential risks and benefits of study participation, an assurance of confidentiality, and the right to refuse or withdraw from the study (ICH 1996; OFR 2002 ). Yet within these guidelines, tremendous variability is found among researchers and institutions in terms of the amount of information provided and the lan guage used. Each researcher is responsible for developing a consent form that includes enough information about a study or procedure to enable a potential participant to make a decision, but not so much as to be overwhelming or as to make an informed choice more difficult (Mack lin 1999). Comprehension of the information is critical for an individual to make an informed decision. Yet, who is re sponsible for ensuring that a participant understands the information? Is it enough for a practitioner to ask whether the person has understood and whether she or he has any questions, or does an obligation exist to ascertain that the person has grasped the information and that she or he is competent to make a decision? Although guidelines em phasize that the investigator is responsible for providing the information in a way that is understandable to the po tential study participants, no specific guidelines explain how investigators should ensure participant comprehen sion ( One critical factor that may diminish autonomy is the power differential between the provider and the poten tial participant. Even in industrialized societies, where individuals may be more involved or have a greater say in their own health care, many may value a physician's opinion above their own (del Carmen and Joffe 2005). A person, even if hesitant about abdicating autonomy and decisionmaking power, might be inclined to agree to a procedure if she or he perceives that a physician advo cates it. Often in research, the physician conducting a study also provides routine care. Patients may feel pres sure to join a study in order to please their physician/ provider or because they fear that choosing not to partici pate will result in poorer care (Macklin 1999). Moreover, providers are often motivated by external factors that may lead them to take a cavalier attitude to the informed consent process.
In addition to the power imbalance between provider and potential participant, other external factors may af fect the decisionmaking process. In many settings, par ticularly in the developing world, individual choice is an unfamiliar concept. Women are not seen as autonomous agents in many countries; they must consult with or even gain permission from their husbands, from other family members, or even from the community at large before making a decision about their own reproductive health. Other populations, such as children and refugees, do not have the power to exercise their own choices (Wood et al. 2002) . Similarly, in highly traditional cultures, the rights or ability of individuals to make decisions, independent of their age, sex, or vulnerability, is often considered sub ordinate to the greater social good, creating conceptual barriers to the implementation of international recom mendations for informed choice and consent. The distinc tion between permission or assent to allow researchers to conduct interviews in a community or to allow a health service to be provided in the locale, and informed con sent, which can be provided only by research participants or clients, is a useful one for addressing this challenge. It does not eliminate, however, the fundamental basis of the rights perspective in the ethical conduct of research or service. Just as the rights of individuals cannot be sub ordinated for the benefit of science, so, too, the rights of individuals to participate or not in research should not be subordinated to the other interests of societies and their opinion leaders. Through documentary-style vignettes, animation, and narration, the video focuses on several themes that were considered to be critical for obtaining truly in formed consent. For example, to convey the concept of voluntary participation, interviews were conducted with one woman who completed the trial and one who chose to withdraw early. Through animation, women learned that although many may be eligible for the trial, only a portion of those may choose to enroll in the study. One scene depicts a counselor and a potential study partici pant going over the informed-consent form. The poten tial participant questions whether she can leave the study after she joins. The counselor reassures her that she can withdraw from the study at any time.
An evaluation of the informed-consent process is underway, including both quantitative and qualitative components. The results of this evaluation will provide useful information about methods and procedures to aid the process of obtaining informed consent in reproduc tive health studies (Friedland et al. no date).
Applications in Service Delivery
In many service-delivery settings, limited resources and policy directives affect the recommendations that provid ers make. In Mexico, for example, the intrauterine device (ILID) is the most common form of reversible contraceptive and is often recommended rather than pills and condoms. At one time, providers were asked to meet monthly targets for RUD insertion and other favored methods that were not dependent on clients' behavior. Although the IUD is a highly effective method for preventing pregnancy, it pro vides no protection from sexually transmitted infections and may cause complications if inserted while a woman has a cervical infection such as gonorrhea or chlamydia. The routine practice in public health clinics in Mexico and elsewhere is for a physician to perform a visual inspection during a pelvic exam prior to providing an IUD. Because more than half of cervical infections are asymptomatic, many women risk IUD insertion while they are infected with chlamydia or gonorrhea in those cases where labora tory testing is not undertaken to rule out STIs.
Researchers hypothesized that if women were given information about STI risks and the three available tem porary contraceptive methods at the public health clin ics (pills, condoms, and IUDs), they would make a bet ter choice for themselves than physicians would in the absence of laboratory tests ( The results of this study were striking. By provid ing women with information about the methods and about STIs, the women were able to make their own risk benefit assessments and choose an appropriate con traceptive method for themselves. It is encouraging to see how many women, when given information and decisionmaking power, will decide correctly.
Efforts to improve informed consent and informed choice require commitment on numerous levels, especial ly from governments and policymakers, to provide the re sources that will allow people to make their own choices. Donors must also fund research on informed consent and informed choice in order to create a body of literature and to facilitate better application of the principle. In summary, adhering to the principle of beneficence requires that risks be minimized, potential benefits en hanced, and benefits outweigh the risks. Deriving a risk benefit ratio is far from being simple or easy, however. First, assessments are typically produced in a qualitative fashion by the principal investigators, who are the most likely to be knowledgeable about the study population and the social, cultural, economic, and political environ ment in which the study will be conducted. Although their analysis may be based on relevant and sound local information, it is necessarily qualitative, and alternate interpretations and opinions can exist. Third, the potential benefits of the research should be defined clearly. In many developing countries, study participation can achieve important gains that are not necessarily the aims of the research. For example, in ar eas where use of health-care services is low, participants' consultations with and examinations by medical person nel that are part of a study protocol may provide them with much-needed medical attention. Some authors have argued that these adjunctive health benefits ought not be considered as part of the risk-benefit analysis because they can imbalance the risk-benefit ratio and provide an inaccurate picture of the research (Emanuel et al. 2000) .
Implicit in these discussions is the potential for a new procedure, device, or practice that is more effective than the existing standard of care. If a consensus has been reached that the existing practice represents the best prac tice or at least a good practice, further research is clearly not justified, and the risk-benefit ratio is likely to be un favorable. The research process is a search for safer and more effective practices that result in both greater knowl edge and better individual outcomes.
A good illustration of this scenario is the debate con cerning the use of a placebo or control arm when a known management or therapy exists. Microbicides are prod ucts being developed to prevent the sexual transmission of HIV. Several candidate microbicides have been tested for safety and feasibility and are undergoing clinical trials for efficacy. Currently, male and female condoms are the only known methods that protect against HIV transmis sion. In microbicide trials, one way to address ethical and scientific questions simultaneously is to test a microbi cide-plus-condom arm against a condom-only arm. This design provides both treatment and control arms with information on the condom, thereby dealing with ethical issues, while concomitantly building in scientific rigor to address the efficacy of the microbicide being tested.
Application of the Principle of Beneficence in the Research Process
Over the years, research on children has received consid erable attention, primarily because children are unable to give consent because of their undeveloped competency. They may not be able to assess adequately the risks and benefits of participating in the research. Ethicists have long debated whether and under what conditions non therapeutic research on children can be undertaken (see Bartholome 1996; Jonsen 1996). Despite children's limited autonomy, some have argued that conducting research on children is permissible if sufficient evidence suggests that exposing some children to risk may result in benefit for many (Jonsen 1996); in such cases, the principle of maxi mizing beneficence takes precedence over autonomy. In many places, children as a group clearly have spe cific needs that require research and inquiry to ameliorate their condition. Worldwide, the HIV!/AIDS epidemic has orphaned hundreds of thousands of children and made many more vulnerable to a variety of social and economic harms. Appropriate interventions must be designed to ad dress such diverse needs as child care, nutrition and food support, educational assistance, and livelihood training to aid the transition to healthy adulthood. Nevertheless, participation in a research study may cause harm. For example, some children may be identified by the com munity as being vulnerable, which may lead to their ex ploitation by unscrupulous people; some children may perceive themselves as being stigmatized; others may undergo psychological trauma as they relive painful ex periences. Such risks can be minimized by a careful choice of research design and methods. For example, in order to protect the very young, age-stratified samples can be used to differentiate between the very young and the young. Age-relevant information can be collected from each group through the use of appropriate data-collection methods designed to minimize intrusion, intimidation, and discomfort. Such methods as participatory mapping exercises are one example of unintrusive methodologies. Employing well-trained data collectors who are also skilled in child psychology may mitigate the traumas that children can face from research participation.
A The unnecessary use of antibiotics leads to antibiotic re sistance among patients and within communities. Con comitantly, those who are infected may be incorrectly diagnosed and treated. This scenario requires that syn dromic management of vaginal discharge cease to be the standard of care that is offered; no management may prove to be a better alternative.
Justice: Equity of Risks and Benefits
The universal principle of justice in the context of re search and service in the field of reproductive health re fers to the fair and equal distribution of the benefits and risks of participation in research, or the equitable access to an array of appropriate services. Participants should be recruited and selected from a pool of potential par ticipants in a fair and equal manner. Furthermore, the principle of justice opposes the exposure of one group of people to the risks of research solely for the benefit of an other group. In other words, it would not permit research to be conducted using individuals from poor communi ties to produce findings solely for the benefit of wealthier individuals. Nor should the benefits of the research fall to the researchers alone, through publications and patents, rather than to those client populations who were partici pants in the research. The application of this principle assumes that the other core principles of respect for the autonomy of indi viduals and of beneficence are also adhered to and that efforts to foster distributive justice is not addressed in iso lation. Of particular concern is the need to provide special protections for vulnerable individuals and groups. With in the field of research ethics, vulnerability refers to the "substantial incapacity to protect one's interests owing to such impediments as lack of capacity to give informed choice, lack of alternative means of obtaining medical care or other expensive necessities, or being a junior or subordinate member of a hierarchical group" (CIOMS 1949). Vulnerable groups typically include minors (in most places, those younger than 18); pregnant women; prisoners and others in institutional custody; people with mental disabilities; those who are socially vulnerable because of their relative lack of education or resources; those who lack access to health-care services; and those who are disadvantaged or discriminated against because of their sex, ethnicity, or lifestyle or circumstance, such as drug users and orphans. In the United States, the Tuskegee syphilis study is the best-known example of how one disadvantaged minority group-rural African-American men-were recruited into a study of a disease that affects individuals from all classes and races. These study participants were denied treatment even when it became available, so that the risks of the research were largely borne by one set of vulnerable individuals who did not benefit from its results.
Of particular importance is the understanding of jus tice as the protection of the participant's or client's broad ly defined interests, not merely his or her physical or psy chological health. The definition of their interests must, therefore, come from the participants rather than from the health system or research team. Participants do not forfeit the right to protections simply because they con sent to participate in a study or agree to accept a service. If they feel their interests are not served, they have the right to withdraw and seek care elsewhere. Even in this context, however, bioethics is less concerned with puni tive or compensatory justice-that is, in punishing those who violate others' rights or compensating those whose rights have been violated. These issues are usually the purview of the legal system. The violation of one's right to justice in the context of research should not, therefore, be viewed as divorced from the legal system. Sponsors of research, including governments, have the right to with draw funding or apply sanctions such as fines whenever they feel that the principle of justice is not being respect ed, and participants retain the right to seek compensation in civil courts should they feel that their health or inter ests have been compromised in the process.
Although the principle of justice evolved from the need to protect some segments of the population from exploitation, a movement to ensure that those who might benefit from the research are not excluded from this pro tection should be advanced. For example, some research ers have argued cogently that underrepresented groups should be included in the research process so that their needs are addressed and so that they can partake of the benefits of the findings (Levine 1996). This need for in clusion is best illustrated by the numbers of people with AIDS in the industrialized world who have advocated for broader access to clinical trials in the hope of some benefit. Other types of research participants who are considered vulnerable and in need of protection and who are increas ingly participating in research are women and children. that preliminary data analysis be conducted to determine whether the expected benefits continue to outweigh the risks for participants. Moreover, the research should contribute to policy development, advocacy, and new intervention models to benefit the community. At a minimum, participants should be informed of the findings of the research and of any findings that relate to their health status. Briefings with community leaders may have to be scheduled, and a formal mechanism be developed for sharing findings with affected individuals. In the circumcision study, the effec tive treatment (that is, the surgical procedure) was offered at no cost to participants in the control sample. Assistance to the media and the public in the use of the research data is also recommended to improve the accuracy of reporting study results and to foster a responsible social reaction.
Application of the Principle of Justice in the Research
Clearly, in the examples of the HPV and circumcision interventions, making these public health interventions available is in the interest of the community and of indi viduals representing the pools from which subjects were recruited. The issues of justice in the service sphere are changed, however, from recruitment and selection to the issues of equity-that is, differential treatment of partici pants based upon their needs and the provision of similar treatment for cases that are similar. Many in the research community contend that these issues are beyond the rea sonable responsibility of researchers. Others, including many reproductive health and HIV advocates, contend that research sponsors and the researchers themselves are responsible for visualizing the end points of the study process and for taking the steps necessary to ensure that the community at large benefits from the study. That this process of careful consideration is feasible is ably demon strated by the South African clinical trial on male circum cision and HIV, where the members of the institutional review board overseeing the trial concerned themselves with the ethics of the study and the protections necessary for the participants. One might argue that if the risks of the research are not great for an individual participant, researchers have a limited responsibility for applying research results to the provision of services. Whatever the level of responsibility, the research community is not absolved of responsibility. The collective interests of the client community are compromised if the health benefits of research as promised in informed-consent documents and in pledges to sponsors do not accrue to the intended beneficiaries.
Conclusions
The ethical issues surrounding research and practice are demonstrably numerous and complex. Rules and guide lines have evolved over the years to respond to contem porary events and circumstances, and we anticipate that they will continue to evolve. In recent years, the HIV/ AIDS pandemic has posed new and challenging ethical problems. The challenges have ranged from balancing ethical principles and finding timely medical and humani tarian solutions to engaging with a wide range of partners in research endeavors.
The range of people and organizations that partici pate in, decide on, and shape the research process is growing. Research is no longer solely the purview of scholars and academics, sponsors, and institutional re view boards. Traditionally, pharmaceutical companies have been able to influence the direction and intensity of research on specific health issues. The pharmaceutical industry has immense influence in bringing resources to bear on topics and products that may have commercial applications. Moreover, the symbiotic relationship be tween the pharmaceutical industry and researchers is such that scarce resources can be appropriated for work on topics that may have vast commercial potential, to the detriment of other topics that may result in little or no commercial gain or in financial setbacks. For example, in the United States, research on and development of new contraceptive methods is thwarted by a perception of a limited return on investments and of the threat of potential lawsuits, in spite of a great latent demand for new products (Schwartz and Gabelnick 2002). In recent decades, new entrants in civil society have emerged who are sophisticated, well organized, and vocal and who ad vocate for research on specific areas and subareas. For ex ample, well-organized and articulate reproductive health activists and advocates were able to influence interna tional opinion and policies at the 1994 Cairo conference, and AIDS activists are continuously engaged in the quest for new drugs and draw attention to gaps in research. In the United States, a group of professional biomedical and health research participants have emerged who negotiate the terms of their participation with researchers concern ing such criteria as compensation and level of surveil lance; they also decide on the extent to which they will comply with the requirements of the protocol (Weinstein 2006). The course of research and the research process will undoubtedly be shaped by the level of participation and discussion by these diverse participants.
In an increasingly global community connected by trade, flow of resources, the Internet, and other commu nication technologies, ideas travel swiftly across national borders. Research participants can be educated to be come empowered and sophisticated, and researchers and sponsors will be required to acknowledge the changed context. Research partnerships between industrialized and developing countries will have to evolve as the lan guage and dynamics of inquiry become standardized to global norms.
As with all endeavors, an emphasis on doing the right thing in the right way requires a commitment of re sources-creative thinking, personnel, and finances. Re searchers must be conscious of the ethical implications of their proposed questions and study methods. Resources are needed to encourage and facilitate researchers to make the transition from a goal of "passing the IRB" as an administrative hurdle to applying ethical principles in the conduct of scientific inquiry. Procedures and sys tems are evolving to increase researchers' adherence to ethical principles. For example, many institutions now prefer that staff members be certified in research ethics by means of courses offered online or elsewhere. Short and long-term courses on research ethics are routinely offered by such institutions and agencies as the National Institutes of Health in the United States. Journals, too, in creasingly require authors to document the ethical pro cedures they have taken during the conduct of a study, including IRB approval and participants' recruitment, and the roles and responsibilities of the authors listed on the manuscript. All of these changes may facilitate better conduct of research for the greater good.
The pursuit of ethical conduct in research and ser vice provision is an unending process. By gathering new knowledge and proposing adjustments, researchers and service providers remain competent and respectful of the ethical review and assurance processes. Fostering great er understanding of the fundamental principles behind these processes and the lessons learned in their applica tion in a diversity of settings is perhaps the only way to ensure that research participants' rights are preserved, protected, and respected.
